Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-20T07:30:28.235Z Has data issue: false hasContentIssue false

Prevalence of the genes for shigella enterotoxins 1 and 2 among clinical isolates of shigella in Israel

Published online by Cambridge University Press:  18 July 2002

M. YAVZORI
Affiliation:
Army Health Branch Research Unit, Medical Corps, Israel Defense Force
D. COHEN
Affiliation:
Army Health Branch Research Unit, Medical Corps, Israel Defense Force Sackler School of Medicine, Tel-Aviv University, Israel
N. ORR
Affiliation:
Army Health Branch Research Unit, Medical Corps, Israel Defense Force Sackler School of Medicine, Tel-Aviv University, Israel
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Two enterotoxins, shigella enterotoxin 1 (SHET1) and shigella enterotoxin 2 (SHET2) have been recently characterized and are believed to play a role in the clinical manifestation of shigellosis. One hundred and twenty-one isolates of Shigella spp. of 13 different serotypes and variants and 10 isolates of enteroinvasive Escherichia coli (EIEC) isolated in Israel, were examined by polymerase chain reaction for the presence of SHET1 and SHET2 genes. SHET1 was only prevalent among isolates of S. flexneri 2a while SHET2 was found in all the serotypes that were tested except for several isolates of S. flexneri 1b that lost their virulence plasmid during storage. In addition, we found that the S. flexneri 2a vaccine strain T-32 Istrati contains the gene encoding for SHET1 but not that encoding for SHET2, suggesting that the latter is located within a large deletion occurring in the 140 Mda plasmid of this S. flexneri 2a non-invasive vaccine strain.

Type
Short Report
Copyright
2002 Cambridge University Press